By Shivani Tanna  (Reuters) - ChatGPT-maker OpenAI has named political veteran Chris Lehane as its vice president of global policy, the New York Times reported on Friday. Lehane, who is a member of the executive team at OpenAI, was a former policy

By Chandni Shah (Reuters) - OpenAI whistleblowers have filed a complaint with the U.S. Securities and Exchange Commission, calling for an investigation over the artificial intelligence company's allegedly restrictive non-disclosure agreements, according to a letter seen by Reuters. "Given the well-documented potential

By Krystal Hu and Akash Sriram (Reuters) - Microsoft-backed OpenAI has acquired search and database analytics startup Rockset to provide better infrastructure for its enterprise products, the ChatGPT maker said on Friday. The companies did not disclose the deal size. OpenAI

By Juveria Tabassum (Reuters) - ChatGPT maker OpenAI's co-founder and former chief scientist Ilya Sutskever said on Wednesday that he was starting a new artificial intelligence company. The company is focused on creating a safe AI environment at a time when some

By Shivani Tanna and Disha Mishra  (Reuters) - OpenAI CEO Sam Altman told some shareholders that the company is considering changing its governance structure to a for-profit business that the firm's nonprofit board doesn't control, The Information reported on Friday. One scenario

By Mike Scarcella (Reuters) - Billionaire entrepreneur Elon Musk on Tuesday moved to dismiss his lawsuit accusing ChatGPT maker OpenAI and its CEO Sam Altman of abandoning the startup's original mission of developing artificial intelligence for the benefit of humanity and

By Jaspreet Singh (Reuters) - Sam Altman-led OpenAI said on Wednesday it has signed content and product partnerships with The Atlantic and Vox Media, helping the artificial intelligence firm to boost and train its products. WHY IT'S IMPORTANT The agreements with The Atlantic

By Anna Tong SAN FRANCISCO - OpenAI's board only learned of the existence of ChatGPT when they saw it on Twitter, former board member Helen Toner said in an interview on "The Ted AI Show" podcast that aired Tuesday. Toner provided her

By Augustin Turpin (Reuters) - French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence. Sanofi said in a statement that the partnership